Verrica Pharmaceuticals Files 8-K on Shareholder Votes

Ticker: VRCA · Form: 8-K · Filed: Jun 5, 2025 · CIK: 1660334

Verrica Pharmaceuticals Inc. 8-K Filing Summary
FieldDetail
CompanyVerrica Pharmaceuticals Inc. (VRCA)
Form Type8-K
Filed DateJun 5, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: corporate-governance, shareholder-vote

Related Tickers: VRCA

TL;DR

VRCA filed an 8-K for shareholder votes. Standard governance stuff.

AI Summary

Verrica Pharmaceuticals Inc. filed an 8-K on June 5, 2025, to report on matters submitted to a vote of its security holders. The filing details the company's corporate structure, including its incorporation in Delaware and its principal executive offices located at 44 West Gay Street, Suite 400, West Chester, PA 19380. The company's telephone number is (484) 453-3300.

Why It Matters

This filing indicates that Verrica Pharmaceuticals is engaging in corporate governance activities, specifically related to decisions requiring shareholder approval, which is a standard but important procedural step for public companies.

Risk Assessment

Risk Level: low — This is a routine filing related to corporate governance and does not appear to contain new material financial or operational information.

Key Players & Entities

  • Verrica Pharmaceuticals Inc. (company) — Registrant
  • June 5, 2025 (date) — Date of Report
  • Delaware (jurisdiction) — State of Incorporation
  • 44 West Gay Street , Suite 400 West Chester , PA 19380 (address) — Principal Executive Offices
  • (484) 453-3300 (phone_number) — Registrant's telephone number

FAQ

What specific matters were submitted to a vote of Verrica Pharmaceuticals Inc. security holders?

The filing states that it is a 'Submission of Matters to a Vote of Security Holders' but does not specify the exact matters in the provided text.

When was the earliest event reported in this 8-K filing?

The earliest event reported is June 5, 2025, which is also the date of the report.

In which state is Verrica Pharmaceuticals Inc. incorporated?

Verrica Pharmaceuticals Inc. is incorporated in Delaware.

What is the principal executive office address for Verrica Pharmaceuticals Inc.?

The principal executive office is located at 44 West Gay Street, Suite 400, West Chester, PA 19380.

What is the IRS Employer Identification Number (EIN) for Verrica Pharmaceuticals Inc.?

The IRS Employer Identification Number for Verrica Pharmaceuticals Inc. is 46-3137900.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 5, 2025 regarding Verrica Pharmaceuticals Inc. (VRCA).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.